Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2021-02-16

FDA Approved: PIPERACILLIN, TAZOBACTAM — Original Application (Sagent Pharmaceuticals)

View source ↗

Summary

FDA approves Sagent Pharmaceuticals' generic Piperacillin-tazobactam for intravenous use under Original Application, enabling a generic version of the antibioti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Piperacillin/tazobactam (Piperacillin/tazobactam)

Snippet

ORIG AP for PIPERACILLIN, TAZOBACTAM (PIPERACILLIN SODIUM, TAZOBACTAM SODIUM)